Last updated on October 2017

Open Label Study to Evaluate Safety Tolerability and Efficacy of Evolocumab (AMG 145) in Pediatric Subjects (10 to 17 Years of Age) With Heterozygous Familial Hypercholesterolemia (HeFH) or Homozygous Familial Hypercholesterolemia (HoFH).


Brief description of study

To describe the safety and tolerability of 80 weeks of subcutaneous (SC) evolocumab (AMG 145) when added to standard of care in pediatric subjects 10 to 17 years of age with HeFH or HoFH.

Detailed Study Description

Colombia pending regulatory approval

Clinical Study Identifier: NCT02624869

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Amgen Call Center

Research Site
Cincinnati, OH United States
  Connect »

Amgen Call Center

Research Site
Camperdown, Australia
  Connect »

Amgen Call Center

Research Site
Feldkirch, Austria
  Connect »

Amgen Call Center

Research Site
Wien, Austria
  Connect »

Amgen Call Center

Research Site
Bruxelles, Belgium
  Connect »

Amgen Call Center

Research Site
Chicoutimi, QC Canada
  Connect »

Amgen Call Center

Research Site
Quebec, QC Canada
  Connect »

Amgen Call Center

Research Site
Svitavy, Czechia
  Connect »

Amgen Call Center

Research Site
Athens, Greece
  Connect »

Amgen Call Center

Research Site
Thessaloniki, Greece
  Connect »

Amgen Call Center

Research Site
Budapest, Hungary
  Connect »

Amgen Call Center

Research Site
Palermo, Italy
  Connect »

Amgen Call Center

Research Site
Pisa, Italy
  Connect »

Amgen Call Center

Research Site
Roma, Italy
  Connect »

Amgen Call Center

Research Site
Torino, Italy
  Connect »

Amgen Call Center

Research Site
Amsterdam, Netherlands
  Connect »

Amgen Call Center

Research Site
Oslo, Norway
  Connect »

Amgen Call Center

Research Site
Parktown, South Africa
  Connect »

Amgen Call Center

Research Site
Geneva 14, Switzerland
  Connect »

Amgen Call Center

Research Site
Reinach, Switzerland
  Connect »

Amgen Call Center

Research Site
Izmir, Turkey
  Connect »